Insights

Strategic partnership Potential for collaboration with Mount Sinai Health System given existing licensing and asset integration, presenting an opportunity to expand commercial reach in personalized cancer therapeutics and scale the PDP platform to additional cancer types.

Funding momentum Recent grants and government funding showcasing validated interest and financial support for personalized therapy matching, suggesting a favorable environment for joint grant-funded pilots or co-development projects to de-risk early deployments.

Small team leverage Current small employee base (2-10) indicates a lean operation that could benefit from strategic outsourcing or channel partnerships to scale sales, customer success, and regulatory/compliance activities without hefty headcount increases.

Clinical adoption potential Unique patient-avatar approach and large-scale drug screening for individual patients align with hospitals, academic centers, and precision oncology programs seeking decision-support tools; target health systems and cancer centers for pilot programs and proof-of-value studies.

Market positioning Position as a comprehensive, FDA-drug-screening–driven personalized treatment selector complements existing genomic/precision oncology offerings; pursue integrations or alignment with genomics labs, tumor boards, and AI-driven decision support ecosystems to expand market access.

Similar companies to My Personal Therapeutics

My Personal Therapeutics Tech Stack

My Personal Therapeutics uses 8 technology products and services including Bioconductor, Matomo, Webpack, and more. Explore My Personal Therapeutics's tech stack below.

  • Bioconductor
    Analytics
  • Analytics
  • Webpack
    Development
  • React
    Javascript Frameworks
  • RequireJS
    Javascript Frameworks
  • TweenMax
    Javascript Frameworks
  • Lodash
    Javascript Libraries
  • Google Analytics
    Web Analytics

Media & News

My Personal Therapeutics's Email Address Formats

My Personal Therapeutics uses at least 2 email formats:
My Personal Therapeutics Email FormatsExamplePercentage
First@mypersonaltherapeutics.comJohn@mypersonaltherapeutics.com
86%
FLast@mypersonaltherapeutics.comJDoe@mypersonaltherapeutics.com
14%

Frequently Asked Questions

What is My Personal Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
My Personal Therapeutics's official website is mypersonaltherapeutics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does My Personal Therapeutics generate?

Minus sign iconPlus sign icon
As of July 2026, My Personal Therapeutics's annual revenue is estimated to be <$1M.

What is My Personal Therapeutics's NAICS code?

Minus sign iconPlus sign icon
My Personal Therapeutics's NAICS code is 62 - Health Care and Social Assistance.

How many employees does My Personal Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2026, My Personal Therapeutics has approximately 2 employees across 1 continents, including Europe. Key team members include Chief Technology Officer: P. C., Non Executive Director: O. S. and Project Manager: A. A. J. Explore My Personal Therapeutics's employee directory with LeadIQ.

What industry does My Personal Therapeutics belong to?

Minus sign iconPlus sign icon
My Personal Therapeutics operates in the Hospitals and Health Care industry.

What technology does My Personal Therapeutics use?

Minus sign iconPlus sign icon
My Personal Therapeutics's tech stack includes Bioconductor, Matomo, Webpack, React, RequireJS, TweenMax, Lodash and Google Analytics.

What is My Personal Therapeutics's email format?

Minus sign iconPlus sign icon
My Personal Therapeutics's email format typically follows the pattern of First@mypersonaltherapeutics.com. Find more My Personal Therapeutics email formats with LeadIQ.

How much funding has My Personal Therapeutics raised to date?

Minus sign iconPlus sign icon
As of July 2026, My Personal Therapeutics has raised $4.6M in funding. The last funding round occurred on Dec 19, 2022.

When was My Personal Therapeutics founded?

Minus sign iconPlus sign icon
My Personal Therapeutics was founded in 2018.
My Personal Therapeutics logo

My Personal Therapeutics

Hospitals and Health CareEngland, United Kingdom2-10 Employees

My Personal Therapeutics is a London-based company operating in the Hospitals and Health Care industry with a small team of 2 to 10 employees, located at London, England SW6 3DT, United Kingdom. The company commercializes a treatment-selection approach originated at the Center for Personalized Cancer Therapeutics at Icahn School of Medicine at Mount Sinai, known as the Personal Discovery Process. The Personal Discovery Process combines whole exome sequencing of tumor and non-tumor tissue, identification of potential tumorigenic mutations, and the use of patient-specific fruit fly avatars, followed by large-scale screening of FDA-approved drugs across approximately 400,000 fruit flies to identify specific drug combinations for individual patients. Using robotics, My Personal Therapeutics evaluates more than 1,200 FDA-approved drugs—including non-cancer drugs—to identify combinations that significantly improve mortality in the avatar population, with the tumor board then making the treatment recommendation. The Personal Discovery Process is described as the most comprehensive drug screening service for individuals with cancer.

Section iconCompany Overview

NAICS Code
62 - Health Care and Social Assistance
Founded
2018
Employees
2-10

Section iconFunding & Financials

  • $4.6M

    My Personal Therapeutics has raised a total of $4.6M of funding over 4 rounds. Their latest funding round was raised on Dec 19, 2022 as a Grant.

  • <$1M

    My Personal Therapeutics's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.